This systematic review explores the integration of environmental sustainability (ES) metrics such as carbon footprinting, life cycle assessment (LCA), and EEIO analysis into health technology assessment (HTA). Drawing on recent trends in pharmaceuticals, medical devices, and procedures, the research identifies how including ES metrics can improve both clinical and economic outcomes in healthcare decision-making.
Key findings reveal vast disparities in the carbon footprint of medical technologies, limited environmental integration in HTA reports, and the need for harmonised standards. The study emphasises embedding ESG principles into procurement and assessment frameworks to drive sustainable innovation. Presented at ISPOR 2025 in Montreal, this work highlights the path toward greener and more resilient healthcare systems.
Please click here to download the poster
Don’t forget to subscribe to our newsletter below for the latest company updates, recently published HTA guidance, industry insights, and more!